234 related articles for article (PubMed ID: 25493621)
1. Short-term Results of Trabeculectomy Using Adjunctive Intracameral Bevacizumab: A Randomized Controlled Trial.
Fakhraie G; Ghadimi H; Eslami Y; Zarei R; Mohammadi M; Vahedian Z; Mafi M; Moghimi S
J Glaucoma; 2016 Mar; 25(3):e182-8. PubMed ID: 25493621
[TBL] [Abstract][Full Text] [Related]
2. Short-term Results of Trabeculectomy Using Adjunctive Intracameral Bevacizumab Versus Mitomycin C: A Randomized Controlled Trial.
Vahedian Z; Mafi M; Fakhraie G; Zarei R; Eslami Y; Ghadimi H; Mohebbi M
J Glaucoma; 2017 Sep; 26(9):829-834. PubMed ID: 28777224
[TBL] [Abstract][Full Text] [Related]
3. Role of subconjunctival bevacizumab as an adjuvant to primary trabeculectomy: a prospective randomized comparative 1-year follow-up study.
Akkan JU; Cilsim S
J Glaucoma; 2015 Jan; 24(1):1-8. PubMed ID: 23661044
[TBL] [Abstract][Full Text] [Related]
4. Subconjunctival bevacizumab versus mitomycin C adjunctive to trabeculectomy.
Nilforushan N; Yadgari M; Kish SK; Nassiri N
Am J Ophthalmol; 2012 Feb; 153(2):352-357.e1. PubMed ID: 21982106
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Adjunctive Subconjunctival Bevacizumab on the Outcomes of Primary Trabeculectomy With Mitomycin C: A Prospective Randomized Placebo-controlled Trial.
Kiddee W; Orapiriyakul L; Kittigoonpaisan K; Tantisarasart T; Wangsupadilok B
J Glaucoma; 2015; 24(8):600-6. PubMed ID: 25393038
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the use of 5-fluorouracil and bevacizumab in primary trabeculectomy: results at 1 year.
Jurkowska-Dudzińska J; Kosior-Jarecka E; Zarnowski T
Clin Exp Ophthalmol; 2012; 40(4):e135-42. PubMed ID: 21668792
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Bevacizumab Compared to Mitomycin C Modulated Trabeculectomy in Primary Open Angle Glaucoma: A One-Year Prospective Randomized Controlled Study.
Kaushik J; Parihar JK; Jain VK; Gupta S; Nath P; Durgapal P; Ram J
Curr Eye Res; 2017 Feb; 42(2):217-224. PubMed ID: 27269279
[TBL] [Abstract][Full Text] [Related]
8. Intracameral bevacizumab as an adjunct to trabeculectomy: a 1-year prospective, randomised study.
Vandewalle E; Abegão Pinto L; Van Bergen T; Spielberg L; Fieuws S; Moons L; Spileers W; Zeyen T; Stalmans I
Br J Ophthalmol; 2014 Jan; 98(1):73-8. PubMed ID: 24158846
[TBL] [Abstract][Full Text] [Related]
9. Intracameral bevacizumab role in trabeculectomy: A 1-year prospective randomized controlled study.
Rabina G; Barequet D; Mimouni M; Kurtz S; Shemesh G; Rosenblatt A; Rosenfeld E
Eur J Ophthalmol; 2020 Nov; 30(6):1356-1361. PubMed ID: 31496260
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal bevacizumab improves trabeculectomy survival at 12 months: the bevacizumab in trabeculectomy study-a randomised clinical trial.
Landers JA; Mullany S; Craig JE
Br J Ophthalmol; 2024 May; 108(5):679-686. PubMed ID: 37541768
[TBL] [Abstract][Full Text] [Related]
11. Evaluation the adjunctive use of combined bevacizumab and mitomycinc to trabeculectomy in management of recurrent pediatric glaucoma.
Mahdy RA; Al-Mosallamy SM; Al-Aswad MA; Bor'i A; El-Haig WM
Eye (Lond); 2016 Jan; 30(1):53-8. PubMed ID: 26427987
[TBL] [Abstract][Full Text] [Related]
12. The Singapore 5-fluorouracil trial: intraocular pressure outcomes at 8 years.
Wong MH; Husain R; Ang BC; Gazzard G; Foster PJ; Htoon HM; Wong TT; Oen FT; Khaw PT; Seah SK; Aung T
Ophthalmology; 2013 Jun; 120(6):1127-34. PubMed ID: 23466269
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of subconjunctival bevacizumab as an adjunct to trabeculectomy a pilot study.
Grewal DS; Jain R; Kumar H; Grewal SP
Ophthalmology; 2008 Dec; 115(12):2141-2145.e2. PubMed ID: 18692246
[TBL] [Abstract][Full Text] [Related]
14. Two-year outcome of repeat trabeculectomy with mitomycin C in primary open-angle and PEX glaucoma.
Meyer LM; Graf NE; Philipp S; Fischer MT; Haller K; Distelmaier P; Schönfeld CL
Eur J Ophthalmol; 2015; 25(3):185-91. PubMed ID: 25449638
[TBL] [Abstract][Full Text] [Related]
15. Needle bleb revision with bevacizumab and mitomycin C compared with mitomycin C alone for failing filtration blebs.
Tai TY; Moster MR; Pro MJ; Myers JS; Katz LJ
J Glaucoma; 2015; 24(4):311-5. PubMed ID: 25826644
[TBL] [Abstract][Full Text] [Related]
16. Long-term Outcomes After Preoperative Intravitreal Injection of Bevacizumab Before Trabeculectomy for Neovascular Glaucoma.
Kobayashi S; Inoue M; Yamane S; Sakamaki K; Arakawa A; Kadonosono K
J Glaucoma; 2016 Mar; 25(3):281-4. PubMed ID: 25580888
[TBL] [Abstract][Full Text] [Related]
17. Surgical outcomes of intravitreal bevacizumab and guarded filtration surgery in neovascular glaucoma.
Fakhraie G; Katz LJ; Prasad A; Eslami Y; Sabour S; Zarei R; Moghimi S
J Glaucoma; 2010 Mar; 19(3):212-8. PubMed ID: 19593201
[TBL] [Abstract][Full Text] [Related]
18. Mitomycin C-augmented trabeculectomy: subtenon injection versus soaked sponges: a randomised clinical trial.
Pakravan M; Esfandiari H; Yazdani S; Douzandeh A; Amouhashemi N; Yaseri M; Pakravan P
Br J Ophthalmol; 2017 Sep; 101(9):1275-1280. PubMed ID: 28100482
[TBL] [Abstract][Full Text] [Related]
19. Assessing safety and success after using bevacizumab, 5-fluorouracil or placebo in primary trabeculectomy. A prospective randomized placebo controlled 1-year follow-up study.
Kandarakis S; Kontaxakis A; Doumazos L; Petrou P; Droutsas K; Papaconstantinou D; Georgalas I
Cutan Ocul Toxicol; 2022 Mar; 41(1):25-32. PubMed ID: 34749555
[TBL] [Abstract][Full Text] [Related]
20. Ab interno trabeculectomy: outcomes in exfoliation versus primary open-angle glaucoma.
Ting JL; Damji KF; Stiles MC;
J Cataract Refract Surg; 2012 Feb; 38(2):315-23. PubMed ID: 22322166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
